Viking Therapeutics Inc (STU:1VT)
€ 29 -0.70 (-2.36%) Market Cap: 3.41 Bil Enterprise Value: 2.79 Bil PE Ratio: 0 PB Ratio: 7.72 GF Score: 38/100

Viking Therapeutics Inc at Leerink Global Healthcare Conference Transcript

Mar 10, 2026 / 02:40PM GMT
Release Date Price: €29.77 (+3.28%)
Thomas Smith
Leerink Partners LLC - Analyst

Great. Good morning, everyone. Thanks for joining us here at day two of the Leerink Partners Global healthcare conference. My name is Tom Smith. I'm one of the senior biotech analysts here at Leerink.

And it's my pleasure to welcome our next company to the stage, Viking Therapeutics, joined by CEO, Brian Lian; CFO, Greg Zante; and Chief Commercial Officer, Neil Aubuchon.

Gentlemen, thanks for joining us. Looking forward to the discussion.

Brian Lian
Viking Therapeutics Inc - President, Chief Executive Officer, Director

Thank you.

Questions & Answers

Thomas Smith
Leerink Partners LLC - Analyst

Such a dynamic space, obesity. A lot of developments, obviously, and you guys had a great year of execution in '25, a number of data sets coming up here in '26 and then some important pivotal data coming in '27. Think there's probably a high awareness of what you guys are up to in the audience.

But Brian, maybe if you want to just talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot